News

In this paper, we show the surprisingly good properties of plain vision transformers for body pose estimation from various aspects, namely simplicity in model structure, scalability in model size, ...
The inaugural Avendus Wealth–Hurun India U30 List 2025 recognizes 79 outstanding Indian entrepreneurs under 30, highlighting the country's next generation of business leaders across diverse sectors.
US judge denies Novartis' injunction request against MSN Pharmaceuticals selling generic Entresto, citing public interest and lack of harm.
Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.
The balanced photodetector (BPD) is an important component for high-speed coherent receiver. An optimization strategy of waveguide-based multi-quantum well (MQW) BPDs, operating at 1550 nm is ...
Biocon, one of India’s leading drugmakers, is aiming to tap into the growing weight-loss market by seeking approvals for generic versions of Ozempic and Wegovy as their patents near expiry next ...
Biocon eyes early lead in generic Wegovy, Ozempic sales in Canada from 2026 The Bengaluru-based company is seeking approval of generic Ozempic by September from Canadian authorities, and also in some ...